Grant of Options, PDMR Dealing & TVR
1 July 2026
MicroSalt Plc
("MicroSalt" or the "Company")
Grant of Options, PDMR Dealing and Total Voting Rights
MicroSalt plc (AIM:SALT), a leading manufacturer of full-flavour natural salt with approximately 50% less sodium, announces that 206,268 ordinary shares of £0.001625 each in the capital of the Company ("Ordinary Shares") ("Option Shares") have been allotted to two shareholders to satisfy the exercise of options over Ordinary Shares.
Options over an aggregate of 228,000 Ordinary Shares were exercised on a cashless basis under an option agreement entered into in September 2023. Due to the cashless basis of the exercise a total of 149,984 Option Shares were allotted and issued. Pursuant to the terms of the option agreement, the exercise price of each Option Share was US$0.25.
In addition, a PDMR has exercised options over 56,284 shares for nil consideration.
Total Voting Rights
The Company has identified certain historical errors with Ordinary Shares having been admitted to trading that had not been allotted or issued to shareholders. The discrepancy relates to the exercise of warrants in 2024, and resulted in 232,519 Ordinary Shares being admitted to trading without having been allotted or issued. As a result, the Company will be cancelling the admission of those 232,519 Ordinary Shares. It is anticipated this cancellation will take effect from 2 July 2026.
Additionally, application has been made to the London Stock Exchange for admission of the Option Shares to trading on AIM ("Admission"). It is expected that Admission will become effective on or around 2 July 2026.
Following the cancellation of Ordinary Shares outlined above, and the issue of the Option Shares, which on Admission will rank pari passu with the existing Ordinary Shares, the total number of Ordinary Shares in issue with voting rights in the Company will be 56,117,642. There are no Ordinary Shares held in treasury.
The above figure of 56,117,642 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information, please contact:
MicroSalt plc
info@microsaltinc.com
Rick Guiney (CEO)
Zeus (Nominated Adviser and Broker)
+44 (0)20 3829 5000
David Foreman / James Edis (Investment Banking)
Dom King (Corporate Broking) / Rupert Woolfenden (Sales)
Gracechurch Group (Financial PR)
+44 (0)20 4582 3500
Heather Armstrong, Alexis Gore, Rebecca Scott
Further information on the Company can be found on its website at: www.microsaltinc.co
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
Further details are set out in the below notification, made in accordance with the requirements of the UK Market Abuse Regulation.
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1
Details of the person discharging managerial responsibilities/person closely associated
a.
Name
Javier Contreras
2
Reason for notification
a.
Position/Status
COO
b.
Initial notification/
Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.
Name
MicroSalt plc
b.
LEI
213800L7WRHP8CCEEQ48
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.
Description of the financial instrument, type of instrument
Identification CodeOrdinary Shares of £0.001625 each
ISIN: GB00BQB6FF85
b.
Nature of the transaction
Exercise of Options
c.
Price(s) and volume(s)
Price(s)
Volume(s)
nil
56,284
d.
Aggregated information
As above
e.
Date of the transactions
24 June 2026
f.
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHEAAKEDLDKEAA
